Enise Ece Gurdal

Enise Ece Gurdal

Auto-generated profile, based on publicly available information

Enise Ece Gurdal

Yeditepe University, Faculty of Pharmacy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BTBengisu Turgutalp
Bengisu Turgutalp
PBPrabesh Bhattarai
Prabesh Bhattarai
TETugba Ercetin
Tugba Ercetin
CLChiara Luise
Chiara Luise
RRRengin Reis
Rengin Reis
MYMine Yarim
Mine Yarim

21 April 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
TOTugce Ozyazici
Tugce Ozyazici
EGEnise E. Gurdal
Enise E. Gurdal
DODuygu Orak
Duygu Orak
Hande SipahiHande Sipahi
Hande Sipahi
TETuba Ercetin
Tuba Ercetin
MKMeric Koksal
Meric Koksal

1 March 2015 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EGEnise Ece Gurdal
Enise Ece Gurdal
EBEbru Buclulgan
Ebru Buclulgan
IDIrem Durmaz
Irem Durmaz
RCRengul Cetin-Atalay
Rengul Cetin-Atalay
MYMine Yarim
Mine Yarim
Synthesis, characterization and cytotoxic activities of ten benzothiazole-piperazine derivatives were reported. In vitro cytotoxic activities of compounds were screened against hepatocellular (HUH-7), breast (MCF-7) and colorectal (HCT-116) cancer cell lines by sulphorhodamine B assay. Based on the GI50 values of the compounds, most of the benzothiazole-piperazine derivatives are active against HUH-7, MCF-7 and HCT-116 cancer cell lines. Aroyl substituted compounds 1h and 1j were found to be the most active derivatives. In addition, further investigation of compounds 1h and 1j by Hoechst staining and FACS revealed that these compounds cause apoptosis by cell cycle arrest at subG1 phase.

8 September 2014 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
EGEnise Ece Gurdal
Enise Ece Gurdal
IDIrem Durmaz
Irem Durmaz
RCRengul Cetin-Atalay
Rengul Cetin-Atalay
MYMine Yarim
Mine Yarim
Synthesis, characterization and cytotoxic activities of ten benzothiazole-piperazine derivatives were reported. In vitro cytotoxic activities of compounds were screened against hepatocellular (HUH-7), breast (MCF-7) and colorectal (HCT-116) cancer cell lines by sulphorhodamine B assay. Based on the GI50 values of the compounds, most of the benzothiazole-piperazine derivatives are active against HUH-7, MCF-7 and HCT-116 cancer cell lines. Compound 1d is highly cytotoxic against all tested cancer cell lines. Further investigation of compound 1d by Hoechst Staining and Fluorescence-Activated Cell Sorting Analysis (FACS) revealed that this compound causes apoptosis by cell cycle arrest at subG1 phase.

9 May 2021 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
MKMeric Koksal
Meric Koksal
ADAyca Dedeoglu‐Erdogan
Ayca Dedeoglu‐Erdogan
MBMarwa Bader
Marwa Bader
EGEnise E. Gurdal
Enise E. Gurdal
Wolfgang SipplWolfgang Sippl
Wolfgang Sippl
TCTurgay Celik
Turgay Celik

11 February 2013 in Drug Research
Verified
Journal Article
Closed access
EGE. E. Gurdal
E. E. Gurdal
MYM. Yarim
M. Yarim
IŞIrem Durmaz Şahin
Irem Durmaz Şahin
RCRengul Cetin-Atalay
Rengul Cetin-Atalay
This study presents the synthesis of nineteen 1-(substitutedbenzoyl)-4-benzhydrylpiperazine and 1-[(substitutedphenyl)sulfonyl]-4-benzhydrylpiperazine derivatives. In vitro cytotoxic activities of the compounds were screened against hepatocellular (HUH-7), breast (MCF-7) and colorectal (HCT-116) cancer cell lines by sulphorhodamine B assay. Among the test compounds, benzamide derivatives had high cytotoxic activity whereas sulfonamide derivatives showed variable 50% growth inhibition (GI50).